Patent ID: 11883571
Assignee: GAMBRO LUNDIA AB
Field: Medical technology (Instruments)
Classification: CPC A | IPC A

Claim 5:
6. The method according to claim 3, wherein the initial set point of the substance in the dialysis fluid is calculated as a function of at least one of the group consisting of:
(i) a weighted difference in concentration of at least one further substance in the dialysis fluid and in the plasma, the substance, whose concentration is to be set, being different from the at least one further substance, the at least one further substance chosen from a group consisting of bicarbonate, potassium, calcium, magnesium, acetate, lactate, citrate, phosphate, and sulphate,
(ii) a molar conductivity of at least one substance in the dialysis fluid chosen from a group consisting of acids and salts of bicarbonate (HCO3−), chloride (Cl−), acetate (CH3COO−), lactate (C3H5O3−), citrate (C6H5O73−), phosphate (PO43−) and sulphate (SO42−), wherein the salts are formed with sodium, potassium, calcium, or magnesium,
(iii) at least a flow rate of dialysate at the outlet of the secondary chamber, or
(iv) at least an efficiency parameter of the filtration unit.